ABSTRACT
No disponible
Subject(s)
Humans , Male , Aged, 80 and over , Erythema Multiforme/chemically induced , Erythema Multiforme/complications , Imiquimod/adverse effects , Erythema Multiforme/drug therapy , Imiquimod/administration & dosage , Methylprednisolone/therapeutic use , Prednisone/therapeutic use , BiopsyABSTRACT
We sought to review the most important updates in the treatment of aspergillosis after the publication of the clinical practice guidelines for the diagnosis and management of invasive aspergillosis (IA) by the Infectious Diseases Society of America. Our aim is to discuss some of the key aspects concerning the following topics: early initiation of antifungal therapy, antifungal agent of choice, follow-up of patients with IA, and breakthrough aspergillosis (AU)
Tras la publicación de la nueva guía de práctica clínica sobre el diagnóstico y manejo de la aspergilosis invasora (AI) de la Infectious Diseases Society of America, se ha realizado una revisión de los puntos más importantes de la actualización del tratamiento de la aspergilosis. Por dicho motivo, a continuación se discutirán los siguientes aspectos claves de interés: tratamiento precoz, tratamiento antifúngico de elección, seguimiento de los pacientes con AI y aspergilosis de brecha (AU)
Subject(s)
Humans , Aspergillosis/diagnosis , Aspergillosis/drug therapy , Antifungal Agents/therapeutic use , Societies, Medical/standards , PrognosisABSTRACT
Primary meningococcal meningitis is an infrequent but known disease. However, the infection of a prosthetic joint with Neisseria meningitidis is rare. We hereby describe the second case of an arthroplasty infected with Neisseria meningitidis that responded favourably to prosthesis retention with surgical debridement, in combination with antibiotics treatment.
